Author: Dr. Shaheen Sahak, MD, MPH
Hypertensive disorders of pregnancy represent one of the most significant causes of maternal and neonatal morbidity and mortality worldwide. These conditions include chronic hypertension, gestational hypertension, preeclampsia, and eclampsia. Collectively, they complicate approximately 8–10% of pregnancies globally and remain a leading contributor to preventable maternal deaths, particularly in low- and middle-income countries.
Preeclampsia alone accounts for a substantial proportion of maternal mortality and is associated with severe complications such as placental abruption, organ dysfunction, preterm birth, and intrauterine growth restriction. The public health burden extends beyond pregnancy, as women with a history of preeclampsia face a two- to four-fold increased risk of developing chronic hypertension and cardiovascular disease later in life.
Hypertension in pregnancy is defined as blood pressure ≥140/90 mmHg during gestation. Global prevalence varies by region, ranging from 7% to 18% in high-income countries and often exceeding 10% in low-resource settings. In sub-Saharan Africa and South Asia, hypertensive disorders account for up to 25% of maternal deaths.
Significant disparities exist across racial, socioeconomic, and geographic groups. In high-income countries, minority populations experience disproportionately higher rates of preeclampsia and related complications, reflecting structural inequities in healthcare access and chronic disease prevalence.
Key risk factors include advanced maternal age (≥35 years), obesity, pre-existing hypertension, diabetes, renal disease, family history of hypertension, primiparity, and multiple gestation pregnancies. The global rise in obesity and delayed childbearing has contributed to increasing incidence trends over recent decades.
Adolescents and women in low-resource settings face additional vulnerability due to limited antenatal care access, low awareness, and delayed diagnosis. Socioeconomic disadvantage remains a major determinant of adverse outcomes.
For mothers, hypertensive disorders increase the risk of stroke, organ failure, placental abruption, and mortality. Eclampsia represents the most severe manifestation, characterized by seizures and life-threatening complications.
Neonatal consequences include preterm birth, low birth weight, intrauterine growth restriction, and increased admission to neonatal intensive care units. These outcomes contribute to long-term developmental and health challenges.
Cohort and case-control studies consistently demonstrate strong associations between modifiable risk factors—particularly obesity and chronic hypertension—and the development of preeclampsia. Prospective cohort designs provide robust outcome tracking, while case-control studies effectively identify causal risk patterns. However, limitations such as recall bias, restricted geographic sampling, and healthcare access variability affect generalizability.
Despite methodological variation, the cumulative evidence supports early screening, risk stratification, and antenatal blood pressure monitoring as essential preventive strategies.
Addressing hypertensive disorders of pregnancy requires integrated public health strategies. Universal access to quality antenatal care, routine blood pressure monitoring, urine protein screening, and timely referral systems are foundational interventions.
Policy priorities should include strengthening maternal health systems, training healthcare providers, implementing national surveillance systems, and promoting preventive strategies targeting obesity and chronic disease among women of reproductive age.
Effective management directly contributes to achieving Sustainable Development Goal 3, which aims to reduce global maternal mortality to fewer than 70 deaths per 100,000 live births.
Hypertension in pregnancy remains a critical global public health challenge with immediate and long-term consequences for mothers and newborns. Rising incidence trends linked to demographic and lifestyle shifts underscore the need for prevention-focused strategies.
Strengthening antenatal care systems, addressing social determinants of health, and integrating hypertension management into broader maternal health frameworks are essential to reducing preventable mortality and improving long-term cardiovascular outcomes.
The complete research document is available upon request. Kindly contact: i@shaheensahak.com